P H Sugarbaker
About
In The Last Decade
P H Sugarbaker
10 papers receiving 500 citations
Peers
Comparison fields: 5 of 56
- Hepatology 310
- Radiology, Nuclear Medicine and Imaging 237
- Epidemiology 167
- Surgery 162
- Oncology 95
Countries citing papers authored by P H Sugarbaker
This map shows the geographic impact of P H Sugarbaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P H Sugarbaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P H Sugarbaker more than expected).
Fields of papers citing papers by P H Sugarbaker
This network shows the impact of papers produced by P H Sugarbaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P H Sugarbaker. The network helps show where P H Sugarbaker may publish in the future.
Co-authorship network of co-authors of P H Sugarbaker
This figure shows the co-authorship network connecting the top 25 collaborators of P H Sugarbaker. A scholar is included among the top collaborators of P H Sugarbaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P H Sugarbaker. P H Sugarbaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. | 60 |
| 2 | 78 | |
| 3 | 194 | |
| 4 | 82 | |
| 5 | Radiolocalization of colon cancer with I-131 B72. 3 monoclonal antibody | 3 |
| 6 | Biodistribution of monoclonal antibody B72. 3(I-131) in colon cancer patients | 1 |
| 7 | 33 | |
| 8 | 31 | |
| 9 | 31 | |
| 10 | 21 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.